Global Drug Discovery Informatics Market

Drug Discovery Informatics Market: Insights

Drug Discovery Informatics helps users to work with huge amounts of data &assists in the management of data collection, analysis, and interpretation. These informatics platforms for drug discovery use bioinformatics algorithms to process data and use several silico models to analyze the data collected. During the projected timeline, growing expenditure on R&D activities and increasing demand for customized medicines are expected to drive growth. Growing funding and demand for orphan drug research & novel drug discovery is also expected to accelerate demand for drug discovery informatics in the market. Furthermore, the increasing use of cloud-based services clubbed with the increasing usage of information technology in data mining and analysis has helped the market grow exponentially from 2020 to 2026.

Drug Discovery Informatics Market: By Application

The market can be split into drug exploration and drug production based on the application segment. The drug development application segment will be the largest market shareholder due to the increasing number of preclinical testing activities.

Drug Discovery Informatics Market: By Solution

As per the solution-based outlook, the segment of the market is services and software. The biggest market share in 2019 was the software attributed to the effective and fast management of data generated using drug discovery software solutions in the drug discovery process.Furthermore, the advantages of informatics software in drug discovery are anticipated to boost the growth for the solution market throughout the forecast period.

Drug Discovery Informatics Market: By Function

According to the function type, this market can be segregated into five segments namely, docking, library & database preparation, sequencing & target data analysis, and molecular modeling, among other functions. The sequencing & target data analysissegment of this market would be the dominating segment as compared to the other functions. This is attributed to the increasing need for sequencing analysis of blockbuster drugs, new entity medicines, and personalized medicines.

Drug Discovery Informatics Market: By End-User

Based on the analysis, the end-user market can be divided into three segments: contract research organizations, pharmaceutical companies, and biotechnology companies, among others. In2019, the pharmaceutical firm is expected to be the largest shareholder. This informatics software is commonly used by pharmaceutical companies for pre-clinical research and development, target recognition, compound monitoring, and lead identification, and streamlining their process of drug discovery.

Drug Discovery Informatics Market: By Region

It is anticipated that the North American region will boost the market shareholder over the expected time frame from 2020-2026. Rising investment in well-established CROs over the projected timeframe is expected. Increasing technological advances in data analytics and mining and rising drug discovery R&D investments would accelerate the development of market growth in the region.On the other hand, due to the growth of biopharmaceutical companies and the rising number of contract research organizations, the Asia Pacific will be the fastest-growing region.

Drug Discovery Informatics Market: Share & Competitor Analysis

The major players competing in this market are Jubilant Life Sciences, CDD, IBM, Accenture, Dassault Systèmes, Evotec Ag, Infosys Limited, Cognizant, Albany Molecular Research, Selvita, GVK Biosciences, IO Informatics, Schrödinger, Certara, Charles River Laboratories International, Clarivate Analytics, Perkinelmer, Eurofins, Scientific Thermo Fisher Scientific, and Openeye Scientific Software, among others.

Please note: This is not an exhaustive list of companies profiled in the report.

In September 2019, Evotec partnered with Takeda Pharmaceutical Company, Ltd. to develop 5 drug discovery initiatives with Evotec clinical candidates across various therapy areas.